Lamprecht and colleagues demonstrated that the activation of an endogenous LTR leads to the expression of colony-stimulating factor 1 receptor (CSF1R), which results oncogenic and correlates with a poor outcome of HL patients [107]. The gene discussed is CSF1R; the disease is Hodgkins lymphoma.